Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Federal Trade Commission
Deloitte
Cantor Fitzgerald
Queensland Health
Johnson and Johnson
Accenture
Chubb
US Army
Cipla

Generated: October 22, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020626

« Back to Dashboard
NDA 020626 describes IMITREX, which is a drug marketed by Glaxosmithkline and is included in three NDAs. It is available from six suppliers. Additional details are available on the IMITREX profile page.

The generic ingredient in IMITREX is sumatriptan succinate. There are twenty-three drug master file entries for this compound. Forty-six suppliers are listed for this compound. Additional details are available on the sumatriptan succinate profile page.

Summary for NDA: 020626

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Antimigraine Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 020626

Suppliers and Packaging for NDA: 020626

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
IMITREX
sumatriptan
SPRAY;NASAL 020626 NDA GlaxoSmithKline LLC 0173-0523 0173-0523-00 6 CONTAINER in 1 BOX (0173-0523-00) > 1 SPRAY in 1 CONTAINER
IMITREX
sumatriptan
SPRAY;NASAL 020626 NDA GlaxoSmithKline LLC 0173-0524 0173-0524-00 6 CONTAINER in 1 BOX (0173-0524-00) > 1 SPRAY in 1 CONTAINER

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:SPRAY;NASALStrength5MG/SPRAY
Approval Date:Aug 26, 1997TE:ABRLD:Yes

Summary for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:SPRAY;NASALStrength10MG/SPRAY
Approval Date:Aug 26, 1997TE:RLD:No

Summary for product number 003

Active Rx/OTC/Discontinued:RXDosage:SPRAY;NASALStrength20MG/SPRAY
Approval Date:Aug 26, 1997TE:ABRLD:Yes

Expired Orange Book Patents for NDA: 020626

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Glaxosmithkline
IMITREX
sumatriptan
SPRAY;NASAL020626-001Aug 26, 1997► Subscribe► Subscribe
Glaxosmithkline
IMITREX
sumatriptan
SPRAY;NASAL020626-003Aug 26, 1997► Subscribe► Subscribe
Glaxosmithkline
IMITREX
sumatriptan
SPRAY;NASAL020626-003Aug 26, 1997► Subscribe► Subscribe
Glaxosmithkline
IMITREX
sumatriptan
SPRAY;NASAL020626-001Aug 26, 1997► Subscribe► Subscribe
Glaxosmithkline
IMITREX
sumatriptan
SPRAY;NASAL020626-002Aug 26, 1997► Subscribe► Subscribe
Glaxosmithkline
IMITREX
sumatriptan
SPRAY;NASAL020626-003Aug 26, 1997► Subscribe► Subscribe
Glaxosmithkline
IMITREX
sumatriptan
SPRAY;NASAL020626-002Aug 26, 1997► Subscribe► Subscribe
Glaxosmithkline
IMITREX
sumatriptan
SPRAY;NASAL020626-001Aug 26, 1997► Subscribe► Subscribe
Glaxosmithkline
IMITREX
sumatriptan
SPRAY;NASAL020626-003Aug 26, 1997► Subscribe► Subscribe
Glaxosmithkline
IMITREX
sumatriptan
SPRAY;NASAL020626-001Aug 26, 1997► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Fuji
Baxter
Queensland Health
Teva
Boehringer Ingelheim
Medtronic
Federal Trade Commission
Cipla
McKinsey
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot